SEPTInvestingStart Free

APVO SCHEDULE 13G/A: SEC filing

Ayrton Capital LLC and related reporting persons

Filed with the SEC on · accession 0001493152-26-051277

APVO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 12, 2026. Ayrton Capital LLC and related reporting persons filed an amended Schedule 13G reporting beneficial ownership of 69,965 shares of Aptevo Therapeutics common stock, representing 3.72% of the class. The stock moved -13.1% by the first close after the filing.

Summary of the filing

Ayrton Capital LLC and related reporting persons filed an amended Schedule 13G reporting beneficial ownership of 69,965 shares of Aptevo Therapeutics common stock, representing 3.72% of the class. The shares are issuable upon exercise of warrants and are subject to a 9.99% beneficial ownership blocker.

For details, click here →

Key details

Shares of common stock beneficially owned (issuable upon exercise of warrants)$70K
Percentage of class beneficially owned$4
Reporting person / investment managerAyrton Capital LLC
Reporting person / holder of warrantsAlto Opportunity Master Fund, SPC - Segregated Master Portfolio B
IssuerAptevo Therapeutics Inc.
Managing member of ayrton capital llcWaqas Khatri

How APVO stock reacted

Close before

$0.76

Nov 11, 2026

First close after

-13.14%

$0.66

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for APVO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for APVO?

Click here

Frequently asked questions

What did APVO file with the SEC on Nov 12, 2026?

APVO filed a SCHEDULE 13G/A (SEC filing). Ayrton Capital LLC and related reporting persons filed an amended Schedule 13G reporting beneficial ownership of 69,965 shares of Aptevo Therapeutics common stock, representing 3.72% of the class. The shares are issuable upon exercise of warrants and are subject to a 9.99% beneficial ownership blocker.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did APVO stock react to this filing?

APVO closed at $0.76 before the filing and $0.66 on Nov 12, 2026 (-13.14%).

Other APVO SEC filings

Get alerts when APVO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
APVO overviewAPVO analysisAPVO newsLatest SEC filings